Senseonics (NYSE:SENS) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright restated a “buy” rating and issued a $2.00 target price on shares of Senseonics in a research note on Wednesday, August 14th.

Senseonics Stock Up 3.6 %

Shares of Senseonics stock opened at $0.36 on Wednesday. The company has a market capitalization of $192.71 million, a P/E ratio of -2.59 and a beta of 0.79. The company has a debt-to-equity ratio of 59.17, a current ratio of 3.11 and a quick ratio of 2.89. The business has a 50-day moving average of $0.37 and a two-hundred day moving average of $0.41. Senseonics has a 1 year low of $0.32 and a 1 year high of $0.75.

Senseonics (NYSE:SENS) last announced its earnings results on Thursday, August 8th. The company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03). Senseonics had a negative net margin of 335.15% and a negative return on equity of 299.69%. The firm had revenue of $4.87 million for the quarter, compared to the consensus estimate of $4.86 million. As a group, equities analysts predict that Senseonics will post -0.13 EPS for the current year.

Institutional Investors Weigh In On Senseonics

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD raised its stake in shares of Senseonics by 16.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after purchasing an additional 51,000 shares in the last quarter. Cubist Systematic Strategies LLC raised its position in Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after acquiring an additional 85,501 shares in the last quarter. Vanguard Group Inc. lifted its stake in Senseonics by 0.7% in the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after acquiring an additional 155,715 shares during the last quarter. State Board of Administration of Florida Retirement System acquired a new stake in Senseonics in the first quarter valued at $91,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in shares of Senseonics by 30.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock valued at $483,000 after acquiring an additional 211,128 shares during the period. 12.36% of the stock is owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.